Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules
NCT ID: NCT00571090
Last Updated: 2014-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
735 participants
OBSERVATIONAL
2003-06-30
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules
NCT01307761
Studies on Tumors of the Thyroid
NCT00001160
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
NCT07124065
Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT01074684
Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography
NCT03294005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thyroid nodule
Subjects who present with thyroid nodules will be enrolled into the study. Euthyroid and hypothyroid subjects with a solitary thyroid nodule or multinodular goiter will be enrolled. For subjects with a suppressed TSH, a thyroid scan will be performed. Subjects with a hypoactive nodule in the thyroid scan and a low TSH will be enrolled.
Thyroid ultrasonography
Ultrasound-guided thyroid fine-needle aspiration biopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thyroid ultrasonography
Ultrasound-guided thyroid fine-needle aspiration biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Euthyroid or hypothyroid subjects with a solitary thyroid nodule or multinodular goiter
* Subjects with a hypoactive nodule in the thyroid scan and a low TSH
Exclusion Criteria
* Subjects with low TSH and hyperactive nodule on thyroid scan
15 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Group Florence Nightingale
OTHER
Istanbul Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmet Selcuk Can
Associate Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmet Selcuk Can, MD
Role: PRINCIPAL_INVESTIGATOR
Istanbul Science University and Group Florence Nightingale
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Group Florence Nightingale
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Can AS. Cost-effectiveness comparison between palpation- and ultrasound-guided thyroid fine-needle aspiration biopsies. BMC Endocr Disord. 2009 May 16;9:14. doi: 10.1186/1472-6823-9-14.
Related Links
Access external resources that provide additional context or updates about the study.
Free research article from the data of this protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
511
Identifier Type: OTHER
Identifier Source: secondary_id
B.30.2.IBU.0.01.00.00/511
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.